Ruakura Technologies
Ruakura Technologies is a New Zealand biotechnology startup developing an immune milk platform that uses dairy cow antibodies, formulated into beverages and chewables, to provide COVID-19 protection for individual consumers.
- Company typePrivate
- Founded2020
- HeadquartersHamilton, New Zealand
- Headcount1–10
- GTM typeB2C
- OfferingHardware or Manufacturing
What Ruakura Technologies does
Ruakura Technologies Ltd is a New Zealand biotechnology startup founded in 2020 and headquartered at the Ruakura Research Centre in Hamilton. The company is developing an immune milk platform that uses designed antigens to immunize dairy cows, generating pathogen-specific antibodies that are transferred into milk. This immune milk is processed into powder and intended to be formulated into oral consumer products such as beverages and chewables. The company's initial product focus is protection against SARS-CoV-2, positioned as a complement to conventional vaccines rather than a replacement.
Ruakura Technologies firmographics
Firmographics- Name
- Ruakura Technologies
- Legal name
- Ruakura Technologies Ltd
- Website
- https://ruatech.co.nz
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Ruakura Technologies is a New Zealand biotechnology startup developing an immune milk platform that uses dairy cow antibodies, formulated into beverages and chewables, to provide COVID-19 protection for individual consumers.
- Ownership category
- akta.pro rank
Ruakura Technologies industry classification
Industry- Product category
- Biotechnology Consumer Products
- NAICS
- Dairy Product Manufacturing (3115), Dairy Product (except Frozen) Manufacturing (31151), Fluid Milk Manufacturing (311511)
- SIC
- Dairy Products (2020), Food And Kindred Products (2000)
- akta.pro primary industry
- Functional & Fortified Dairy Drinks (Vitamins/Minerals, Lactose-Free, A2, Added Fiber) (AFAHAIAE)
- akta.pro secondary industry
- Dairy-Based Beverages Manufacturing (Flavored Milk, Lassi, Drinkable Yogurt) (AFAKAKAH)
Keywords
Where Ruakura Technologies is headquartered
LocationHeadquarters
- HQ city
- Hamilton
- HQ country
- New Zealand
- HQ region
- Oceania
Offices1 record
Markets served
Ruakura Technologies business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Supply Chain
Revenue model
- Immune Milk Consumer Products: Products under development - immune milk powder formulated into consumer products (beverages and chewables) for discretionary consumer use. Revenue model not yet disclosed as company is pre-revenue with products in development stage.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
Ruakura Technologies product offering
Product offeringCore offering
Ruakura Technologies is developing an immune milk platform that uses designed antigens for targeted human pathogens to immunize dairy cows, generating pathogen-specific antibodies in their milk. The resulting immune milk powder is being formulated into consumer products (beverages and chewables) for oral consumption, with the initial focus on providing protective effects against SARS-CoV-2/COVID-19.
Product overview
Ruakura Technologies operates an immune milk platform as its core technology, which generates specific antibodies in dairy cows through targeted antigen immunization. The immune milk is processed into immune milk powder, which serves as the raw material for formulating consumer products. The company's initial product portfolio focuses on COVID-19 protective consumer products for oral consumption (beverages or chewables), with the platform designed to be adaptable to other viral and microbial pathogens beyond SARS-CoV-2.
Differentiator
Problem solved
Functional benefit
Products and services
- Immune Milk Platform
Companies that use Ruakura Technologies
Customer profileSegments1 record
Ideal customer profiles1 record
Ruakura Technologies technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Ruakura Technologies partnerships and signals
Strategic signalScale indicators1 record
Recent moves5 records
Expansion highlights3 records
Ruakura Technologies competitors and assessment
Company assessmentDirect peers
- Immuron: Australian-listed biotech commercialising hyperimmune bovine colostrum products (e.g., Travelan, Protectyn) targeting gut and respiratory pathogens. Direct peer using dairy cows to generate pathogen-specific antibodies for human consumer/therapeutic products.
- PanTheryx: US-based company commercialising bovine colostrum-based immune products across consumer and paediatric nutrition. Closely comparable dairy-cow antibody platform with established distribution and commercial revenue.
- SAb Biotherapeutics: Clinical-stage biotech using genetically engineered cattle to produce fully human polyclonal antibodies against infectious diseases. Most direct scientific analogue: same core concept (cows as antibody bioreactors for human pathogens) but at clinical stage.
- Symbiotics / APS Biogroup: Producer of hyperimmune colostrum and immune egg products targeted at human immune health, including COVID-era products. Directly comparable hyperimmune dairy platform addressing similar consumer immune-protection use cases.
Broad incumbents
- AgriLabs / Huvepharma (colostrum lines): Large animal-health and nutrition companies with established bovine colostrum and immune-milk product lines for human and veterinary markets. Comparable dairy-antibody production model at industrial scale.
- Glanbia Nutritionals: Large global dairy ingredients and bioactive-protein manufacturer with capability in functional dairy beverages. Comparable as a scaled dairy-based functional beverage manufacturer and potential partner/competitor in immune-support drinks.
- Fonterra (ingredients and ventures): New Zealand-headquartered global dairy cooperative with major R&D investment in functional dairy ingredients and bioactive proteins. Comparable as NZ-based, large-scale dairy processor with capacity to license or partner on novel milk bioactives.
Regional players
- Synlait Milk: New Zealand-based specialty dairy processor with R&D capability in functional and nutritional milk products. Regional peer with infrastructure, NZ presence, and capability to manufacture or partner on immune-milk consumer products.
Emerging players
- BioGaia: Swedish probiotics and immune-health consumer health company with established retail distribution for discretionary immune-support products. Comparable as a science-led, small-cap consumer immune-health brand rather than in core mechanism.
Others
- Callaghan Innovation: New Zealand government innovation agency that has already funded RuaTech. Not a commercial peer but a relevant ecosystem participant that signals NZ R&D infrastructure backing.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat2 records
Key risks7 records
Key highlights6 records
Customer concentration
Ruakura Technologies social profiles
Digital presenceRuakura Technologies financial estimates
Financial estimateRevenue estimate
Valuation estimate
Ruakura Technologies leadership team
Management profileNumber of profiles
Profiles6 records
Ruakura Technologies funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Ruakura Technologies M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Ruakura Technologies
What does Ruakura Technologies do?
Ruakura Technologies is developing an immune milk platform that uses designed antigens for targeted human pathogens to immunize dairy cows, generating pathogen-specific antibodies in their milk. The resulting immune milk powder is being formulated into consumer products (beverages and chewables) for oral consumption, with the initial focus on providing protective effects against SARS-CoV-2/COVID-19.
Is Ruakura Technologies a public or private company?
Ruakura Technologies is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Ruakura Technologies founded?
Ruakura Technologies was founded in 2020. It employs 1 to 10 people.
Where is Ruakura Technologies based?
Ruakura Technologies is headquartered in Hamilton, New Zealand, in the Oceania region.
How does Ruakura Technologies make money?
One revenue line is on record: immune Milk Consumer Products.
Who are Ruakura Technologies's main competitors?
Direct peers on record are Immuron, PanTheryx, SAb Biotherapeutics and Symbiotics / APS Biogroup. Broad incumbents are AgriLabs / Huvepharma (colostrum lines), Glanbia Nutritionals and Fonterra (ingredients and ventures). Synlait Milk is listed as a regional player. BioGaia is listed as an emerging player. Callaghan Innovation is listed as an others.
Does Ruakura Technologies have an API?
No public API is recorded for Ruakura Technologies.
What industry is Ruakura Technologies in?
Ruakura Technologies's product category is Biotechnology Consumer Products. Its primary akta.pro industry code is AFAHAIAE, Functional & Fortified Dairy Drinks (Vitamins/Minerals, Lactose-Free, A2, Added Fiber), with a secondary code of AFAKAKAH, Dairy-Based Beverages Manufacturing (Flavored Milk, Lassi, Drinkable Yogurt). Its NAICS code is 3115 and its SIC code is 2020.